| FACILITY DESIGN AND OPERATIONS |
Jennifer Markarian
Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
read more
| CONTAINER CLOSURES |
Agnes Shanley
As closure integrity testing moves from a probabilistic to a deterministic basis, designs are promoting improved control and reduced operator contact.
read more
| FROM THE EDITOR |
Rita C. Peters
Frustrated with high costs and drug shortages, hospitals adopt a DIY approach.
read more
| REGULATORY BEAT |
Jill Wechsler
Manufacturers tackle regulatory and competitive issues to develop complex therapies and biosimilars.
read more
| ASK THE EXPERT |
Susan J. Schniepp
Regardless of the phase of development and the level of GMPs being applied, there should be adequate controls and knowledge to assure patient safety.
read more
|